Compounds > podophyllotoxin
Page last updated: 2024-08-21

podophyllotoxin and Uveal Neoplasms

podophyllotoxin has been researched along with Uveal Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
All-Ericsson, C; Andersson, S; Axelson, M; Economou, MA; Girnita, A; Girnita, L; Larsson, O; Menu, E; Seregard, S; Vasilcanu, D2
All-Ericsson, C; Aström, K; Axelson, M; Economou, MA; Girnita, A; Girnita, L; Larsson, O; Seregard, S2
Economou, MA1

Other Studies

6 other study(ies) available for podophyllotoxin and Uveal Neoplasms

ArticleYear
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:6

    Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferation; Cell Survival; Humans; Melanoma; Mice; Mice, SCID; Neoplasm Transplantation; Podophyllotoxin; Receptor, IGF Type 1; Specific Pathogen-Free Organisms; Transplantation, Heterologous; Tumor Cells, Cultured; Uveal Neoplasms; Vascular Endothelial Growth Factor A

2008
Introduction: Uveal melanoma.
    Acta ophthalmologica, 2008, Volume: 86 Thesis 4

    Topics: Administration, Oral; Animals; Humans; Melanoma; Neoplasm Metastasis; Podophyllotoxin; Prognosis; Proto-Oncogene Proteins c-met; Receptor, IGF Type 1; Uveal Neoplasms; Vascular Endothelial Growth Factor A

2008
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Acta ophthalmologica, 2008, Volume: 86 Thesis 4

    Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracellular Matrix Proteins; Humans; Matrix Metalloproteinase Inhibitors; Melanoma; Mice; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Phosphorylation; Podophyllotoxin; Receptor, IGF Type 1; Transplantation, Heterologous; Uveal Neoplasms

2008
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
    Acta ophthalmologica, 2008, Volume: 86 Thesis 4

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Survival; Humans; Melanoma; Mice; Mice, SCID; Neoplasm Transplantation; Podophyllotoxin; Receptor, IGF Type 1; Transplantation, Heterologous; Uveal Neoplasms; Vascular Endothelial Growth Factor A

2008
Uveal melanoma and macular degeneration: molecular biology and potential therapeutic applications.
    Acta ophthalmologica, 2008, Volume: 86, Issue:8

    Topics: Animals; Biomarkers; Humans; Macular Degeneration; Melanoma; Mice; Molecular Biology; Podophyllotoxin; Prognosis; Receptor, IGF Type 1; Signal Transduction; Uveal Neoplasms; Vascular Endothelial Growth Factor A

2008
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-15, Volume: 12, Issue:4

    Topics: Animals; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, SCID; Neoplasm Invasiveness; Phosphorylation; Podophyllotoxin; Receptor, IGF Type 1; Uveal Neoplasms; Xenograft Model Antitumor Assays

2006